SCHEMBL4656372

SCHEMBL4656372

CC(N)N1C(=O)Cc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.49
HPGD P15428 1/20 0.47
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
OPRM1 P35372 5/20 0.43
OPRK1 P41145 5/20 0.43
OPRL1 P41146 4/20 0.43
CASP3 P42574 2/20 0.41
CASP6 P55212 2/20 0.41
SENP8 Q96LD8 2/20 0.41
SENP7 Q9BQF6 2/20 0.41
SENP6 Q9GZR1 2/20 0.41
KMT2A Q03164 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
GAA P10253 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4200813 0.85 NOTUM (0.51) NOTUMHPGDCHRNB4CHRNA3OPRM1
SCHEMBL3227444 0.82 NOTUM (0.49) NOTUMHPGDCHRNB4CHRNA3OPRM1
SCHEMBL21142478 0.79 NOTUM (0.46) NOTUMHPGDCHRNB4CHRNA3OPRM1
SCHEMBL8669245 0.78 HPGD (0.44) NOTUMHPGDCHRNB4CHRNA3OPRM1
SCHEMBL5122585 0.78 NOTUM (0.45) NOTUMHPGDCHRNB4CHRNA3OPRM1
SCHEMBL4553514 0.78 NOTUM (0.53) NOTUMHPGDCHRNB4CHRNA3OPRM1
SCHEMBL22401875 0.77 NOTUM (0.44) NOTUMHPGDCHRNB4CHRNA3OPRM1
SCHEMBL5989585 0.73 NOTUM (0.55) NOTUMHPGDCHRNB4CHRNA3OPRM1
SCHEMBL7207045 0.73 NOTUM (0.44) NOTUMHPGDCHRNB4CHRNA3OPRM1
SCHEMBL5504251 0.73 CASP3 (0.43) NOTUMHPGDCHRNB4CHRNA3OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210169892-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC 2021-06-10 US disclosed
EP-1706113-B1 A PROCESS FOR THE PREPARATION OF 4-(2-DIPROPYLAMINOETHYL)-1,3-DIHYDRO-2H-INDOL-2-ONE HYDROCHLORIDE USV LTD (IN) 2008-12-10 EP disclosed
US-7378439-B2 Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride USV, LTD. (IN) 2008-05-27 US disclosed
CN-1909901-A A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride USV LTD (IN) 2007-02-07 CN disclosed
EP-1706113-A1 A PROCESS FOR THE PREPARATION OF 4-(2-DIPROPYLAMINOETHYL)-1,3-DIHYDRO-2H-INDOL-2-ONE HYDROCHLORIDE USV Limited (IN) 2006-10-04 EP disclosed
WO-2005067922-A1 A PROCESS FOR THE PREPARATION OF 4-(2-DIPROPYLAMINOETHYL)-1,3-DIHYDRO-2H-INDOL-2-ONE HYDROCHLORIDE USV LIMITED (IN) 2005-07-28 WO disclosed
US-20050159605-A1 Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride USV LIMITED (IN) 2005-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050159605-A1 Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride PARK7, SNCA, TPH1 NOTUM 3620/4885HPGD 1152/4885CHRNB4 216/4885
US-20210169892-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 NOTUM 4116/4885HPGD 861/4885CHRNB4 4097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.